◆英語タイトル:Northwest Biotherapeutics Inc (NWBO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011100
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is a personalized immune therapy and consists of therapeutic vaccine which uses patient’s own dendritic cells as the therapeutic agent. The product has two components, namely, dendritic cells (immune cells) and antigens (cancer biomarkers). The company’s product lines include DCVax-L, for the treatment of glioblastoma multiforme (GBM) brain cancer (Phase III) and metastatic ovarian cancer (Phase I completed); DCVax-Direct, for the treatment of all inoperable solid tumor cancers (Phase I/II underway); and DCVax-Prostate, for the treatment of late stage prostate cancer. NW Bio is headquartered in Bethesda, Maryland, the US.
Northwest Biotherapeutics Inc (NWBO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Northwest Biotherapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Northwest Biotherapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Northwest Biotherapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Northwest Biotherapeutics Raises Funds through Private Placement 10
Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 11
Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 13
Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 14
Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 15
Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 16
Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 17
Debt Offering 18
Northwest Biotherapeutics Completes Private Placement Of Convertible Notes For US$3 Million 18
Northwest Biotherapeutics Inc – Key Competitors 19
Northwest Biotherapeutics Inc – Key Employees 20
Northwest Biotherapeutics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Corporate Communications 22
Jun 13, 2016: NW Bio Announces Scientific Advisory Board 22
Legal and Regulatory 24
Oct 25, 2017: NW Bio Reports Favorable Results and Progress In Resolving Lawsuits 24
Dec 19, 2016: NW Bio Announces Initiation Of Trading On The OTCQB Marketplace Starting On Monday Morning, December 19, 2016 26
Other Significant Developments 27
Oct 17, 2017: NW Bio Leases Out Warehouse On UK Property to Major Commodities Distribution Firm 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Northwest Biotherapeutics Inc, Medical Equipment, Key Facts, 2016 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Northwest Biotherapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Northwest Biotherapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Northwest Biotherapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Northwest Biotherapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Northwest Biotherapeutics Raises Funds through Private Placement 10
Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 11
Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 13
Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 14
Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 15
Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 16
Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 17
Northwest Biotherapeutics Completes Private Placement Of Convertible Notes For US$3 Million 18
Northwest Biotherapeutics Inc, Key Competitors 19
Northwest Biotherapeutics Inc, Key Employees 20
Northwest Biotherapeutics Inc, Subsidiaries 21